FDA — authorised 29 December 1989
- Marketing authorisation holder: BAUSCH AND LOMB
- Status: approved
🇺🇸 Optipranolol in United States
FDA authorised Optipranolol on 29 December 1989
Marketing authorisation
Optipranolol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Optipranolol approved in United States?
Yes. FDA authorised it on 29 December 1989.
Who is the marketing authorisation holder for Optipranolol in United States?
BAUSCH AND LOMB holds the US marketing authorisation.